|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/06 | (2006.01) |
| C07D 401/06 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/06 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/08 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3252047 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17168752.8 |
| Date of filing the European patent application | 2008-03-25 | |
| (97) | Date of publication of the European application | 2017-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 910379 P | 2007-04-05 | US | |
| 976546 P | 2007-10-01 | US | |
| 31554 | 2008-02-26 | US |
| (72) |
CAMPETA, Anthony, Michael , US
CHEKAL, Brian, Patrick , US
MCLAUGHLING, Robert, William , US
SINGER, Robert, Alan , US
|
| (73) |
Pfizer Products Inc. ,
Eastern Point Road, Groton, CT 06340,
US
|
| (54) | CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALS |
| CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALS |